Combined expertise in medicine, molecular biology and global business development, is hard to find!What drives me as an accomplished international executive leader: Pushing the boundaries of science and medicine to improve healthcare; Spearheading global development & commercialization of innovative drugs, devices and diagnostics; Unyieldingly driving business to success. Most recently, this led to the M&A of SonoVol Inc by PerkinElmer - February 2022.I have been afforded broad exposure to the newest trends in diagnostic, device and drug discoveries in a wide range of human disease areas. These insights have empowered me to accurately identify and assess global business development opportunities and strategies. My MO: If you want to rise to success fast, find your lowest hanging fruit and laser focus!It is my strong belief that communication with the end user (C-level, investors, governments, KOL’s, PhD's, MD's, veterinarians and patients) is center stage to business development. I have a knack for intuitively uncovering and creating solutions for the metaphorical "bleeding neck" principle. I count this ability as one of the greatest strengths of my strategic competence.Business Development: The 3 criteria for success: 1) an innovative product that works; 2) market demand; 3) a solid team. Strategy: Focus, Priority, lowest hanging fruit first.Expertise: win-win negotiator, global sales, marketing, technical support, M&A's, alliances, licensing and co-marketing agreements, exit strategy.Scientific Expertise: 1) 20 years of drug development; 2) Veterinary surgeon; 3) PhD in Molecular Biology: gene profiling in placenta, cloning, pre-eclampsia ART, IVF, ET, AI, PDG; 4) Medical Imaging: Optical (bioluminescence, fluorescence, chemiluminescence, Cherenkov), PET, SPECT, CT, MRI, US, intra-surgical fluorescence imaging; Radioligands and Radiotheranostics; 5) Translational models: oncology, immunology, liver, kidney, infection, inflammation, CNS, aging, bone, lung, cardiovascular, rare disease; 6) Biomarkers; antibodies & peptides CMO; 7) Drug delivery, Cell & Gene therapy, stem cells, CAR-T, CRISPR, RNA, ADC; 8) Synthetic biology; 9) Diagnostics: omics, ELISA, aptamers, phage, HCS, flow cytometry, molecular imaging probes.Philanthropy: I lead the "Brain Leadership Performance" catalyzer program in which I educate executives, entrepreneurs and their teams the practical neuroscience that underpins leadership, peak performance, alignment, inclusive culture, growth and success. “Master Your Brain, Master Your Power... visit: www.dralexdelille.com